Hyperspectral VSFG Microscopy for Label-Free Tumor Tissue Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional VSFG spectroscopy is limited in measuring molecular structures of materials lacking inversion centers, leading to ensemble-averaged information and mischaracterization of local heterogeneities, and existing label-free imaging techniques for biomedical applications are time-consuming and limited in multiplexed detection.
Innovation Solution
A multimodal nonlinear hyperspectral VSFG microscope platform using a pulsed laser beam, optical parametric amplifier, and resonant beam scanner to achieve high spatial resolution and label-free identification of tumor tissues by analyzing collagen structures through NHS/CH2,Ss and CHS/CH2,Ss ratio mapping.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional VSFG spectroscopy with large illumination area (100 μm) is used, then ensemble-averaged information is obtained, but local heterogeneities are mischaracterized and signal cancellations occur
Solution Approach 1:
The patent segments the illumination area from 100 μm down to 1 μm scale using a line-scanning VSFG microscopy approach. This segmentation allows the system to resolve local heterogeneities and avoid signal cancellations while maintaining chemical specificity through vibrational spectroscopy of collagen structures.
2Measurement precision
If tissue staining with dyes or probes is used for label-free imaging, then specific tissue components are labeled, but time-consuming fixation and staining processes are required
Solution Approach 1:
The patent employs label-free VSFG imaging that utilizes the intrinsic vibrational properties of collagen molecules themselves. The collagen structures in tumor tissues naturally provide the VSFG signal through their non-centrosymmetric arrangement, eliminating the need for external dyes or probes and their associated time-consuming processing steps.
3Quantity of substance
If traditional VSFG with ensemble averaging is used, then chemical profiling is achieved, but tumor vs healthy tissue differentiation is limited
Solution Approach 1:
The patent applies local quality analysis by examining VSFG signals at the 1 μm spatial scale rather than ensemble-averaging over 100 μm. This reveals local variations in collagen structure, orientation, and density that are characteristic of tumor versus healthy tissue, enabling accurate differentiation through spatially-resolved chemical imaging.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, high-fidelity differentiation between tumor and healthy tissues with 1 μm spatial resolution, preserving sample integrity and providing chemical-specific domain details for cancer diagnosis.
Implementation Method 1
an optical parametric amplifier (OPA), configured to guide the output of the laser beam, generating a mid-infrared (MIR) beam
Implementation Method 2
a dichroic mirror (DM) that is transmissive to the MIR and reflective to the NIR
Implementation Method 3
Vibrational sum-frequency generation (VSFG), a second-order nonlinear optical technique
Data Source
AI summary
A multimodal hyperspectral vibrational sum-frequency generation (VSFG) platform and a method of tumor diagnosis are provided. The method employs the chemical-specific VSFG microscopy platform as a label-free imaging technique for tumor identification.